Cardinal Health, Inc. (CAH, Financial) recently held its 2024 Annual Meeting of Shareholders on November 6, 2024. The meeting, which took place at the company's headquarters in Dublin, Ohio, covered several significant proposals that were put to a vote by the shareholders.
One of the primary outcomes of the meeting was the election of 10 nominees to the company's Board of Directors. These individuals will serve until the 2025 Annual Meeting of Shareholders, or until their successors are duly elected and qualified. This decision ensures continuity in leadership and strategic direction for Cardinal Health.
Additionally, shareholders approved, on a non-binding advisory basis, the compensation of the company's named executive officers. This "say-on-pay" vote reflects shareholder support for the company's executive compensation practices.
Another critical decision was the ratification of Ernst & Young LLP as Cardinal Health's independent auditor for the fiscal year ending June 30, 2025. This ratification underscores the company's commitment to maintaining transparency and integrity in its financial reporting.
However, not all proposals were approved. Shareholders did not pass a proposal that sought to prohibit the re-nomination of any director who fails to receive a majority vote. This outcome indicates a preference for maintaining flexibility in director nominations.
The results of this meeting highlight Cardinal Health's ongoing efforts to engage with its shareholders and align its governance practices with shareholder interests. For more detailed information on the proposals and voting outcomes, investors are encouraged to review the company's definitive proxy statement filed with the Securities and Exchange Commission.
Should you invest in Cardinal Health Inc (CAH, Financial) right now? Before you do it, it’s important to understand the business profitability and stock valuations, and find out what the warning signs are about. See the in-depth Cardinal Health Inc (CAH) stock research here.
